135 related articles for article (PubMed ID: 16026494)
1. Genotype A1/A2 associated with neuroleptic malignant syndrome.
Del Tacca M; Lattanzi L; Lastella M; Di Paolo A; Mungai F; Danesi R; Menichetti F; Dell'osso L; Cassano GB
Bipolar Disord; 2005 Aug; 7(4):390-1. PubMed ID: 16026494
[No Abstract] [Full Text] [Related]
2. Genetic predisposition to neuroleptic malignant syndrome in siblings.
Ziegenbein M; Kropp S; Hillemacher T; Bleich S
Ann Pharmacother; 2006 Mar; 40(3):574-5. PubMed ID: 16478811
[No Abstract] [Full Text] [Related]
3. Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome.
Suzuki A; Kondo T; Otani K; Mihara K; Yasui-Furukori N; Sano A; Koshiro K; Kaneko S
Am J Psychiatry; 2001 Oct; 158(10):1714-6. PubMed ID: 11579007
[TBL] [Abstract][Full Text] [Related]
4. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
Gram LF
Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
[No Abstract] [Full Text] [Related]
5. Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.
Matsumoto R; Kitabayashi Y; Nakatomi Y; Tsuchida H; Fukui K
Am J Psychiatry; 2005 Apr; 162(4):812. PubMed ID: 15800166
[No Abstract] [Full Text] [Related]
6. Exacerbation of idiopathic priapism with risperidone-citalopram combination.
Freudenreich O
J Clin Psychiatry; 2002 Mar; 63(3):249-50. PubMed ID: 11926728
[No Abstract] [Full Text] [Related]
7. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
[TBL] [Abstract][Full Text] [Related]
8. A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.
Ochi S; Kawasoe K; Abe M; Fukuhara R; Sonobe K; Kawabe K; Ueno S
Gen Hosp Psychiatry; 2011; 33(6):640.e1-2. PubMed ID: 21749835
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome with risperidone.
Gleason PP; Conigliaro RL
Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome (NMS) associated with amisulpride and sertraline use: A case report and discussion.
Uvais NA; Gangadhar P; Sreeraj VS; Rafeeque PA
Asian J Psychiatr; 2019 Mar; 41():82-83. PubMed ID: 29174670
[No Abstract] [Full Text] [Related]
11. Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.
Duggal HS; Kithas J
Am J Psychiatry; 2005 Feb; 162(2):397-8. PubMed ID: 15677611
[No Abstract] [Full Text] [Related]
12. Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene.
Kishida I; Kawanishi C; Furuno T; Matsumura T; Hasegawa H; Sugiyama N; Suzuki K; Yamada Y; Kosaka K
Psychiatr Genet; 2003 Mar; 13(1):55-7. PubMed ID: 12605103
[TBL] [Abstract][Full Text] [Related]
13. Comment: delayed risperidone-induced neuroleptic malignant syndrome.
Sitarz WE
Ann Pharmacother; 1996 Nov; 30(11):1342-3. PubMed ID: 8913427
[No Abstract] [Full Text] [Related]
14. Quetiapine and citalopram: aetiological significances in serotonin syndrome.
Marlowe K; Schirgel D
N Z Med J; 2006 Jul; 119(1237):U2058. PubMed ID: 16862204
[TBL] [Abstract][Full Text] [Related]
15. Torsade de pointes during combined treatment with risperidone and citalopram.
Blaschke D; Parwani AS; Huemer M; Rolf S; Boldt LH; Dietz R; Haverkamp W
Pharmacopsychiatry; 2007 Nov; 40(6):294-5. PubMed ID: 18030657
[No Abstract] [Full Text] [Related]
16. Risperidone and neuroleptic malignant syndrome.
Tarsy D
JAMA; 1996 Feb; 275(6):446. PubMed ID: 8627964
[No Abstract] [Full Text] [Related]
17. [Malignant neuroleptic syndrome associated to risperidone].
Aguirre C; García Monco JC; Mendibil B
Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
[No Abstract] [Full Text] [Related]
18. [Neuroleptic malignant syndrome associated with olanzapine].
García López MM; Ciprés L; de Cendra E; Vilalta Franch J
Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
[No Abstract] [Full Text] [Related]
19. [Drug-induced neuroleptic malignant syndrome].
Jitsuiki H; Yamashita H; Kozuru T; Yamawaki S
Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1627-33. PubMed ID: 17802712
[No Abstract] [Full Text] [Related]
20. Neurotoxic syndrome associated with risperidone and fluvoxamine.
Reeves RR; Mack JE; Beddingfield JJ
Ann Pharmacother; 2002 Mar; 36(3):440-3. PubMed ID: 11895057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
